Tereticornate A suppresses RANKL-induced osteoclastogenesis via the downregulation of c-Src and TRAF6 and the inhibition of RANK signaling pathways-Reference-Cited by-同舟云学术

Tereticornate A suppresses RANKL-induced osteoclastogenesis via the downregulation of c-Src and TRAF6 and the inhibition of RANK signaling pathways

Published:2022-07 Issue: Volume:151 Page:113140
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Liu Titi,Jiang Li,Xiang Zemin,Li Jin,Zhang Yaqi,Xiang Ting,Wang Wei,Li Xiaofeng,Jia Yuankan,Huang Xueqin,Lu Xiaofang,Xu Huanhuan,Wang Xuanjun,Sheng Jun

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference36 articles.

1. Diterpenoid suppresses osteoclastogenesis and promotes osteogenesis by inhibiting ifrd1-mediated and ikappabalpha-mediated p65 nuclear translocation;Xie;J. Bone Min. Res.,2018

2. Anacardic acid inhibits RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced bone loss in vivo;Zhao;FASEB J.,2019

3. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities;Liu;Theranostics,2019

4. Pseurotin a inhibits osteoclastogenesis and prevents ovariectomized-induced bone loss by suppressing reactive oxygen species;Chen;Theranostics,2019

5. RANK-L and RANK: T cells, bone loss, and mammalian evolution;Theill;Annu. Rev. Immunol.,2002

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of the PI3K/Akt pathway in adenosine’s mechanism of action in osteoporosis with oxidative stress: A wet-dry experimental approach strategy;Journal of Functional Foods;2024-09

2. The Evaluation of Anti-Osteoclastic Activity of the Novel Calcium Hydroxide Biodegradable Nanoparticles as an Intracanal Medicament;Journal of Endodontics;2024-05

3. Quinoa alleviates osteoporosis in ovariectomized rats by regulating gut microbiota imbalance;Journal of the Science of Food and Agriculture;2024-02-15

4. Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets;Molecular Medicine;2024-02-03

5. Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis;Journal of Translational Medicine;2023-11-22